Eurofarma Laboratórios S.A. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net income was BRL 170.84 million compared to BRL 241.35 million a year ago. Basic earnings per share from continuing operations was BRL 0.173 compared to BRL 0.2811 a year ago. Diluted earnings per share from continuing operations was BRL 0.173 compared to BRL 0.2811 a year ago.
For the nine months, net income was BRL 417.57 million compared to BRL 691.78 million a year ago. Basic earnings per share from continuing operations was BRL 0.4228 compared to BRL 0.8056 a year ago. Diluted earnings per share from continuing operations was BRL 0.4228 compared to BRL 0.8056 a year ago.